Source link : https://www.newshealth.biz/health-news/alzheimers-data-withdrawn-medpage-today/
A preprint research letter linking the Alzheimer’s drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The preprint was posted on Research Square and had not been peer-reviewed, but its findings were publicized by articles in Science and the New York Times. Led by Alberto Espay, MD, MSc, a Parkinson’s disease and movement disorders […]
Author : News Health
Publish date : 2024-11-11 22:43:42
Copyright for syndicated content belongs to the linked Source.
inHealth